When Treatment Is Mitigated by Adverse Events- The Economic Impact of Treatment-Associated Adverse Events in Cirrhotic Non-Responders Treated with Boceprevir or Telaprevir and Peginterferon Alpha/Ribavirin

Nov 1, 2013, 00:00
10.1016/j.jval.2013.08.167
https://www.valueinhealthjournal.com/article/S1098-3015(13)02072-X/fulltext
Title : When Treatment Is Mitigated by Adverse Events- The Economic Impact of Treatment-Associated Adverse Events in Cirrhotic Non-Responders Treated with Boceprevir or Telaprevir and Peginterferon Alpha/Ribavirin
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(13)02072-X&doi=10.1016/j.jval.2013.08.167
First page : A350
Section Title : Disease-Specific Studies
Open access? : No
Section Order : 154
Categories :
Tags :
Regions :
ViH Article Tags :